Osiris Therapeutics, Inc. Common Stock
OSIR
OSIR was delisted on the 16th of April, 2019.
67 hedge funds and large institutions have $109M invested in Osiris Therapeutics, Inc. Common Stock in 2014 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 17 reducing their positions, and 8 closing their positions.
35% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 17
0% more funds holding
Funds holding: 67 → 67 (0)
0% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 8
18% less capital invested
Capital invested by funds: $133M → $109M (-$23.6M)
88% less call options, than puts
Call options by funds: $611K | Put options by funds: $4.91M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$4.91M |
| 2 |
Renaissance Technologies
New York
|
+$760K |
| 3 |
Millennium Management
New York
|
+$665K |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$554K |
| 5 |
NCCM
Nine Chapters Capital Management
Short Hills,
New Jersey
|
+$454K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
-$5.57M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$782K |
| 3 |
WC
Woodstock Corp
Boston,
Massachusetts
|
-$272K |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$265K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$242K |
OSIR Hedge Fund Activity: Q3 2014 in Review
67 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Osiris Therapeutics, Inc. Common Stock (OSIR) for Q3 2014, worth a combined $109M — down 18% from $133M a quarter earlier.
Fund positioning in OSIR was balanced in Q3 2014: 8 funds opened new positions, 8 closed out, 23 added to existing stakes and 17 trimmed.
The largest buyer was Deerfield Management, adding an estimated $4.91M. The largest seller was Consonance Capital Management, cutting an estimated $5.57M.
- 67 institutional investors held Osiris Therapeutics, Inc. Common Stock (OSIR) as of Q3 2014, unchanged from Q2 2014.
- Funds reported $109M of Osiris Therapeutics, Inc. Common Stock stock for Q3 2014, down 18% quarter-over-quarter.
- 8 funds opened new Osiris Therapeutics, Inc. Common Stock positions in Q3 2014 and 8 closed out, a net change of 0 holders.
- The largest Osiris Therapeutics, Inc. Common Stock buyer in Q3 2014 was Deerfield Management, an estimated $4.91M added.
- The largest Osiris Therapeutics, Inc. Common Stock seller in Q3 2014 was Consonance Capital Management, an estimated $5.57M sold.
Based on aggregated 13F filings for Q3 2014.